@ChartGuys I love this and more people should be just completely ignoring it. It’s not what real traders do. If you’re a successful trader with years of practice you avoid plays like this one.
@DekmarTrades The ones making money on these are NOT the seasoned good trades. Only traders that are blindly buying and getting lucky. No point in chases these with any sort of size
$AIM 0.2635 could follow! $SBFM $GOVX soaring! $AIM hasn't and fits the theme!
AIM ImmunoTech is actively developing its investigational drug, Ampligen (rintatolimod), as a potential prophylactic and early-onset therapy for Ebola virus disease (EVD). Pre-clinical studies have shown that the drug offers 100% protection in lethal Ebola mouse infection models